Jing Yang

Jing Yang

Auto-generated profile, based on publicly available information

Jing Yang

Department of Biochemistry and Molecular Biology, Basic Medical College, Jinzhou Medical University, No.40, Section 3 Songpo Road, Linghe District, Jinzhou, Liaoning 121001, China; Provincial Key Laboratory of Cardiovascular and Cerebrovascular Drug Basic Research, Jinzhou Medical University, No.40, Section 3 Songpo Road, Linghe District, Jinzhou, Liaoning 121001, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2023 in Dementia and Geriatric Cognitive Disorders
Verified
Journal Article
Closed access
PDF file
RNRodgers Odhiambo Ndolo
Rodgers Odhiambo Ndolo
YLYu Lu
Yu Lu
YZYan Zhao
Yan Zhao
JLJin-Ying Lu
Jin-Ying Lu
GWGao Wang
Gao Wang
JYJing Yang
Jing Yang
Introduction: Carnosine can suppress secondary complications in diabetes and show robust neuroprotective activity against neurodegenerative diseases. Here, we report that carnosine ameliorates diabetes-associated cognitive decline in vivo through the modulation of autophagy. Methods: A high-fat diet (HFD) and one intraperitoneal injection of 30 mg/kg streptozotocin (STZ) were used to induce type 2 diabetes mellitus in Sprague-Dawley rats. The rats were randomly divided into five groups: control (CON), HFD/STZ, and three intragastric carnosine treatment groups receiving low (100 mg/kg), medium (300 mg/kg), and high (900 mg/kg) doses over 12 weeks. Body weight, blood glucose levels, and cognitive function were continuously monitored. From excised rat hippocampi, we determined superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels; carnosine concentration; protein expressions of Akt, mTOR and the autophagy markers LC3B and P62 and performed histopathological evaluations of the cornu ammonis 1 region. Results: The HFD/STZ group showed increased blood glucose levels and decreased body weight compared to the CON group. However, there were no significant differences in body weight and blood glucose levels between carnosine-treated and -untreated HFD-STZ-induced diabetic rats. Diabetic animals showed obvious learning and memory impairments in the Morris water maze test compared to the CON group. Compared to those in the HFD/STZ group, carnosine increased SOD activity and decreased MDA levels, increased hippocampal carnosine concentration, increased p-Akt and p-mTOR expression, decreased LC3B and P62 expression, alleviated neuronal injuries, and improved cognitive performance in a dose-dependent manner. Conclusion: Independent of any hyperglycemic effect, carnosine may improve mild cognitive impairments by mitigating oxidative stress, activating the Akt/mTOR pathway, and modulating autophagy in the hippocampus of type 2 diabetic rats.

17 June 2026 in Phytomedicine
Verified
Journal Article
Closed access
NWNanding Wu
Nanding Wu
YWYutong Wang
Yutong Wang
MGMengjie Guo
Mengjie Guo
RRRuili Ran
Ruili Ran
DWDewei Wang
Dewei Wang
YYYue Yang
Yue Yang

6 October 2025 in European Journal of Pharmacology
Verified
Journal Article
Closed access
RRRuili Ran
Ruili Ran
YWYutong Wang
Yutong Wang
YLYing Liu
Ying Liu
DWDewei Wang
Dewei Wang
NWNanding Wu
Nanding Wu
JYJing Yang
Jing Yang

10 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
INIrene Njoka
Irene Njoka
ITInnocent Tesha
Innocent Tesha
YWYutong Wang
Yutong Wang
MGMengjie Guo
Mengjie Guo
WNWu Nanding
Wu Nanding
JYJing Yang
Jing Yang
Background: Ischemic stroke burden in sub-Saharan Africa is rising, yet county-level evidence for Kenya's devolved health system remains scarce. We estimated ischemic stroke burden across Kenya's 47 counties (1990–2023) and forecasted trends to 2033 to inform decentralized policy interventions. Methods: Using GBD 2023 data, we estimated stroke incidence, prevalence, mortality, and DALYs by age, sex, and county. Joinpoint regression analyzed 1990–2023 trends (EAPC, 95% CI); ARIMA projected 2024–2033 burden. Comparative risk assessment quantified attributable factors. Findings: In 2023, Ischaemic stroke caused 11,328 deaths and 317,719 DALYs nationally. Age-standardized incidence rose slightly (EAPC 0·22%), while mortality and DALY rates declined significantly (EAPCs −0·69% and −0·45%). County-level disparities were pronounced: Kwale had the highest incidence (108·97 per 100,000), Garissa the highest mortality (46·49), and Siaya the lowest incidence (57·77). High systolic blood pressure contributed to 35% of the burden. Mortality declines accelerated after Kenya's 2013 devolution. Projections indicate mortality falling to 20–22per 100,000 by 2033, yet incidence plateauing at 85–86 per100, 000 signaling treatment gains but stalled prevention. Working-age men (40–65) experienced the highest mortality burden, though women exceeded men at ages 85+.I nterpretation: Ischaemic stroke remains a major cause of death and disability. Rising incidence alongside declining mortality signals treatment success but persistent prevention gaps. Evidence confirms devolved governance improves healthcare access and outcomes. African nations should adopt decentralized models, strengthen primary prevention, and advance universal health coverage to manage the growing disability burden.

7 October 2026 in The Lancet Regional Health - Africa
Verified
Journal Article
Open access
INIrene M. Njoka
Irene M. Njoka
ITInnocent Tesha
Innocent Tesha
YWYutong Wang
Yutong Wang
MGMengjie Guo
Mengjie Guo
WNWu Nanding
Wu Nanding
JYJing Yang
Jing Yang